Sun Pharmaceutical Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharmaceutical Industries has announced that the trading window for dealing in its shares will be closed from 1 July 2025 until 48 hours after the declaration of its unaudited financial results for the quarter ended 30 June 2025 (Q1 FY26). This is a routine compliance measure under SEBI's Insider Trading Regulations and the company's own code of conduct. The date of the board meeting to approve the Q1 results has not yet been announced and will be communicated later. The filing was made by Anoop Deshpande, the Company Secretary and Compliance Officer, on 26 June 2025.
No direct impact on shareholders. This is a standard regulatory disclosure that temporarily restricts insiders from trading the stock ahead of the quarterly earnings announcement, signaling that Q1 FY26 results are likely due in the next few weeks.